$EGAN
EGAIN Corp

2024 Q1 Form 10-Q Financial Statement

#000155837024000894 Filed on February 08, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4
Revenue $22.35M $23.82M
YoY Change -2.88% -6.97%
Cost Of Revenue $6.858M $6.990M
YoY Change -9.7% 3.52%
Gross Profit $15.49M $16.83M
YoY Change 0.48% -10.73%
Gross Profit Margin 69.32% 70.65%
Selling, General & Admin $7.899M $7.740M
YoY Change -14.54% -32.38%
% of Gross Profit 50.99% 46.0%
Research & Development $6.655M $6.660M
YoY Change -0.48% -7.35%
% of Gross Profit 42.96% 39.58%
Depreciation & Amortization $92.00K $94.00K
YoY Change -25.81% -24.8%
% of Gross Profit 0.59% 0.56%
Operating Expenses $14.55M $14.40M
YoY Change -8.64% -22.73%
Operating Profit $938.0K $2.425M
YoY Change -283.2% 1038.5%
Interest Expense $1.002M $982.0K
YoY Change 22.49% 85.63%
% of Operating Profit 106.82% 40.49%
Other Income/Expense, Net $74.00K -$697.0K
YoY Change -130.2% 27.89%
Pretax Income $2.014M $2.710M
YoY Change 3201.64% 1275.63%
Income Tax $521.0K $525.0K
% Of Pretax Income 25.87% 19.37%
Net Earnings $1.493M $2.185M
YoY Change -501.34% -2200.96%
Net Earnings / Revenue 6.68% 9.17%
Basic Earnings Per Share $0.05 $0.07
Diluted Earnings Per Share $0.05 $0.07
COMMON SHARES
Basic Shares Outstanding 31.20M 31.49M
Diluted Shares Outstanding 31.60M 31.84M

Balance Sheet

Concept 2024 Q1 2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $82.98M $86.83M
YoY Change 2.06% 7.38%
Cash & Equivalents $82.98M $86.83M
Short-Term Investments
Other Short-Term Assets $1.317M $1.175M
YoY Change 21.61% 92.94%
Inventory
Prepaid Expenses $2.387M $2.157M
Receivables $10.95M $14.27M
Other Receivables $0.00 $0.00
Total Short-Term Assets $98.89M $105.7M
YoY Change 2.39% 4.15%
LONG-TERM ASSETS
Property, Plant & Equipment $483.0K $561.0K
YoY Change -28.55% -34.99%
Goodwill $13.19M $13.19M
YoY Change 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.954M $1.768M
YoY Change 68.89% 75.57%
Total Long-Term Assets $21.43M $19.72M
YoY Change 3.72% -6.83%
TOTAL ASSETS
Total Short-Term Assets $98.89M $105.7M
Total Long-Term Assets $21.43M $19.72M
Total Assets $120.3M $125.4M
YoY Change 2.62% 2.26%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.534M $1.777M
YoY Change 2.61% 48.58%
Accrued Expenses $5.615M $4.207M
YoY Change 2.0% -17.43%
Deferred Revenue $34.34M $40.88M
YoY Change -2.18% -2.13%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $49.62M $53.29M
YoY Change -1.67% -3.98%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $887.0K $896.0K
YoY Change 8.44% 12.99%
Total Long-Term Liabilities $887.0K $896.0K
YoY Change 8.44% 12.99%
TOTAL LIABILITIES
Total Short-Term Liabilities $49.62M $53.29M
Total Long-Term Liabilities $887.0K $896.0K
Total Liabilities $56.46M $58.65M
YoY Change 1.9% -4.33%
SHAREHOLDERS EQUITY
Retained Earnings -$325.2M -$326.7M
YoY Change -2.66% -2.1%
Common Stock $405.6M $404.4M
YoY Change 1.51% 1.59%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $63.86M $66.79M
YoY Change
Total Liabilities & Shareholders Equity $120.3M $125.4M
YoY Change 2.62% 2.26%

Cashflow Statement

Concept 2024 Q1 2023 Q4
OPERATING ACTIVITIES
Net Income $1.493M $2.185M
YoY Change -501.34% -2200.96%
Depreciation, Depletion And Amortization $92.00K $94.00K
YoY Change -25.81% -24.8%
Cash From Operating Activities $1.748M $7.696M
YoY Change 93.15% 3.79%
INVESTING ACTIVITIES
Capital Expenditures $14.00K $105.0K
YoY Change -118.67% -39.31%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$14.00K -$105.0K
YoY Change -118.67% -39.31%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -5.354M -1.628M
YoY Change 436.47% -266.97%
NET CHANGE
Cash From Operating Activities 1.748M 7.696M
Cash From Investing Activities -14.00K -105.0K
Cash From Financing Activities -5.354M -1.628M
Net Change In Cash -3.620M 5.963M
YoY Change 20011.11% -27.43%
FREE CASH FLOW
Cash From Operating Activities $1.748M $7.696M
Capital Expenditures $14.00K $105.0K
Free Cash Flow $1.734M $7.591M
YoY Change 76.94% 4.82%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
dei Entity Central Index Key
EntityCentralIndexKey
0001066194
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-35314
dei Entity Registrant Name
EntityRegistrantName
eGain Corporation
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
77-0466366
dei Entity Address Address Line1
EntityAddressAddressLine1
1252 Borregas Avenue
dei Entity Address City Or Town
EntityAddressCityOrTown
Sunnyvale
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94089
dei City Area Code
CityAreaCode
408
dei Local Phone Number
LocalPhoneNumber
636-4500
dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
dei Trading Symbol
TradingSymbol
EGAN
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
31202603
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
86833000
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
73201000
CY2023Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
7000
CY2023Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
7000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
109000
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
237000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
14271000
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
31569000
CY2023Q4 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
1282000
CY2023Q2 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
1317000
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
2157000
CY2023Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
2466000
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
1175000
CY2023Q2 us-gaap Other Assets Current
OtherAssetsCurrent
1268000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
105725000
CY2023Q2 us-gaap Assets Current
AssetsCurrent
109828000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
561000
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
633000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2200000
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2797000
CY2023Q4 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
2003000
CY2023Q2 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
2318000
CY2023Q4 us-gaap Goodwill
Goodwill
13186000
CY2023Q2 us-gaap Goodwill
Goodwill
13186000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1768000
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1355000
CY2023Q4 us-gaap Assets
Assets
125443000
CY2023Q2 us-gaap Assets
Assets
130117000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1777000
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
2044000
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
5842000
CY2023Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
7697000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4207000
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5387000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
587000
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
832000
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
40880000
CY2023Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
47762000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
53293000
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
63722000
CY2023Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
2991000
CY2023Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
2101000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1470000
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1762000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
896000
CY2023Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
836000
CY2023Q4 us-gaap Liabilities
Liabilities
58650000
CY2023Q2 us-gaap Liabilities
Liabilities
68421000
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
60000000
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
60000000
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
32462000
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
32268000
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
31202000
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
31482000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
32000
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
32000
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
404320000
CY2023Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
401087000
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
1260000
CY2023Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
786000
CY2023Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
8778000
CY2023Q2 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
5763000
CY2023Q4 egan Notes Receivable From Stockholders
NotesReceivableFromStockholders
20000
CY2023Q2 egan Notes Receivable From Stockholders
NotesReceivableFromStockholders
97000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2101000
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2122000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-326660000
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-331441000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
66793000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
61696000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
125443000
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
130117000
CY2023Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
23815000
CY2022Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
25600000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
47991000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
50363000
CY2023Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
6990000
CY2022Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
6752000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
13828000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
13034000
CY2023Q4 us-gaap Gross Profit
GrossProfit
16825000
CY2022Q4 us-gaap Gross Profit
GrossProfit
18848000
us-gaap Gross Profit
GrossProfit
34163000
us-gaap Gross Profit
GrossProfit
37329000
CY2023Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6660000
CY2022Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7188000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
13292000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
14062000
CY2023Q4 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
5349000
CY2022Q4 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
8895000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
11453000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
18354000
CY2023Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2391000
CY2022Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2552000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5577000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5370000
CY2023Q4 us-gaap Operating Expenses
OperatingExpenses
14400000
CY2022Q4 us-gaap Operating Expenses
OperatingExpenses
18635000
us-gaap Operating Expenses
OperatingExpenses
30322000
us-gaap Operating Expenses
OperatingExpenses
37786000
CY2023Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
2425000
CY2022Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
213000
us-gaap Operating Income Loss
OperatingIncomeLoss
3841000
us-gaap Operating Income Loss
OperatingIncomeLoss
-457000
CY2023Q4 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
982000
CY2022Q4 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
529000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
1931000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
815000
CY2023Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-697000
CY2022Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-545000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-87000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
265000
CY2023Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2710000
CY2022Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
197000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
5685000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
623000
CY2023Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
525000
CY2022Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
301000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
904000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
743000
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
2185000
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-104000
us-gaap Net Income Loss
NetIncomeLoss
4781000
us-gaap Net Income Loss
NetIncomeLoss
-120000
CY2023Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.07
CY2022Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.15
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2023Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.07
CY2022Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.15
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2023Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31179000
CY2022Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32018000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31329000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31975000
CY2023Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31843000
CY2022Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32018000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31991000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31975000
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
2185000
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-104000
us-gaap Net Income Loss
NetIncomeLoss
4781000
us-gaap Net Income Loss
NetIncomeLoss
-120000
CY2023Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
776000
CY2022Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
945000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
21000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-206000
CY2023Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2961000
CY2022Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
841000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
4802000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-326000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
64265000
CY2023Q4 us-gaap Repayments Of Debt
RepaymentsOfDebt
44000
CY2023Q4 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
409000
CY2023Q4 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
417000
CY2023Q4 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
2498000
CY2023Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1195000
CY2023Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
776000
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
2185000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
66793000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
57785000
CY2022Q4 egan Paid In Kind Interest On Stockholder Loan
PaidInKindInterestOnStockholderLoan
-1000
CY2022Q4 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
435000
CY2022Q4 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
540000
CY2022Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1771000
CY2022Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
945000
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-104000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
61371000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
61696000
us-gaap Repayments Of Debt
RepaymentsOfDebt
77000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
413000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
417000
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
3015000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2403000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
21000
us-gaap Net Income Loss
NetIncomeLoss
4781000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
66793000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
56857000
egan Paid In Kind Interest On Stockholder Loan
PaidInKindInterestOnStockholderLoan
-1000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
465000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
540000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3836000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-206000
us-gaap Net Income Loss
NetIncomeLoss
-120000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
61371000
us-gaap Profit Loss
ProfitLoss
4781000
us-gaap Profit Loss
ProfitLoss
-120000
us-gaap Amortization Of Deferred Sales Commissions
AmortizationOfDeferredSalesCommissions
845000
us-gaap Amortization Of Deferred Sales Commissions
AmortizationOfDeferredSalesCommissions
770000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
596000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
552000
egan Depreciation And Amortization Of Capital Lease Assets
DepreciationAndAmortizationOfCapitalLeaseAssets
204000
egan Depreciation And Amortization Of Capital Lease Assets
DepreciationAndAmortizationOfCapitalLeaseAssets
251000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-2000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
101000
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
251000
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
202000
us-gaap Share Based Compensation
ShareBasedCompensation
2403000
us-gaap Share Based Compensation
ShareBasedCompensation
3836000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
2000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-17333000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-10353000
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
486000
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
409000
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-308000
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-470000
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-88000
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-270000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
166000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-30000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-267000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-509000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-1856000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-2241000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1185000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
175000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-6048000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-4638000
egan Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-536000
egan Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-516000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
65000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
4000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
15826000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
8175000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
135000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
293000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-135000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-293000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
413000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
465000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
417000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
540000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
3015000
egan Proceeds From Repayment Of Notes Receivable Due From Stockholders
ProceedsFromRepaymentOfNotesReceivableDueFromStockholders
77000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2108000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1005000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
49000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-193000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
13632000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
8694000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
73208000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
72180000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
86840000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
80874000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
972000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1230000
us-gaap Nature Of Operations
NatureOfOperations
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><b style="font-weight:bold;">Organization and Nature of Business</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">eGain Corporation (eGain, the Company, our, we or us) automates customer engagement with an innovative knowledge hub, powered by conversational artificial intelligence (AI) and analytics. We sell mostly to large enterprises across financial services, telecommunications, retail, government, healthcare, and utilities seeking to better serve customers at scale while coping with content silos, process complexity, and regulatory compliance. With our mantra of <b style="font-weight:bold;">AX + BX + CX = DX™</b>, we guide clients to effortless digital experience (DX) by holistically optimizing agent experience (AX), business experience (BX), and customer experience (CX). Leading brands use eGain’s cloud software to improve customer satisfaction, empower agents, reduce service cost, and boost sales. We are headquartered in the United States. We also operate in the United Kingdom and India.</p>
us-gaap Fiscal Period
FiscalPeriod
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><b style="font-weight:bold;">Fiscal Year</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><span style="font-size:10pt;margin-bottom:5pt;margin-top:5pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The Company fiscal year ends on June 30. References to fiscal year 2024 refers to fiscal year ending June 30, 2024.</p>
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><b style="font-weight:bold;">Use of Estimates</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The preparation of financial statements requires us to make estimates and assumptions in the condensed consolidated financial statements and accompanying notes. Actual results could differ significantly from estimates. We make estimates that we believe to be reasonable based on historical experience and other assumptions. Significant estimates and assumptions made by management include the following:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Standalone selling price (SSP) of performance obligations for contracts with multiple performance obligations;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Estimate of variable consideration for performance obligations in connection with Topic 606;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Period of benefit associated with capitalized costs to obtain revenue contracts;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Valuation, measurement and recognition of current and deferred income taxes;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Fair value of stock-based awards; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Lease term and incremental borrowing rate for lease liabilities.</span></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p>
egan Number Of Revenue Categories
NumberOfRevenueCategories
2
egan Revenue Payment Term Minimum
RevenuePaymentTermMinimum
P30D
egan Revenue Payment Term Maximum
RevenuePaymentTermMaximum
P45D
CY2023Q4 egan Contract Cost Capitalized During Period
ContractCostCapitalizedDuringPeriod
397000
egan Contract Cost Capitalized During Period
ContractCostCapitalizedDuringPeriod
486000
CY2023Q4 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
345000
us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
845000
CY2022Q4 egan Contract Cost Capitalized During Period
ContractCostCapitalizedDuringPeriod
218000
egan Contract Cost Capitalized During Period
ContractCostCapitalizedDuringPeriod
409000
CY2022Q4 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
395000
us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
770000
CY2023Q4 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
3300000
CY2023Q2 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
3600000
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2022Q4 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2023Q4 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
egan Number Of Operating Regions
NumberOfOperatingRegions
3
CY2022Q4 egan Number Of Operating Regions
NumberOfOperatingRegions
3
egan Number Of Operating Regions
NumberOfOperatingRegions
3
CY2023Q4 egan Number Of Operating Regions
NumberOfOperatingRegions
3
CY2023Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
2425000
CY2022Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
213000
us-gaap Operating Income Loss
OperatingIncomeLoss
3841000
us-gaap Operating Income Loss
OperatingIncomeLoss
-457000
CY2023Q4 us-gaap Noncurrent Assets
NoncurrentAssets
561000
CY2023Q2 us-gaap Noncurrent Assets
NoncurrentAssets
633000
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><b style="font-weight:bold;">Concentration of Credit Risk and Significant Customers </b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Our financial instruments that are exposed to concentrations of credit risk include cash and cash equivalents, restricted cash, and accounts receivable. We complement direct sales with resell partnerships based on product connectors into cloud contact center platforms. We also partner with system integrators and managed service providers. One customer, who is also a partner, accounted for 19% and 18% of total revenue during the three and six months ended December 31, 2023, respectively. The same partner and a different partner, accounted for 19% and 10%, respectively, of total revenue during the three months ended December 31, 2022 and 21% and 8%, respectively, for the six months ended December 31, 2022.<b style="font-weight:bold;"> </b>Three customers accounted for more than 10% of our gross accounts receivable balance as of December 31, 2023.</p>
egan Number Of Customers And Partners That Accounted For More Than Ten Percentage Of Revenue
NumberOfCustomersAndPartnersThatAccountedForMoreThanTenPercentageOfRevenue
1
CY2023Q4 egan Number Of Customers And Partners That Accounted For More Than Ten Percentage Of Revenue
NumberOfCustomersAndPartnersThatAccountedForMoreThanTenPercentageOfRevenue
1
CY2023Q4 egan Number Of Customers That Accounted For More Than Ten Percent Of Companys Accounts Receivable
NumberOfCustomersThatAccountedForMoreThanTenPercentOfCompanysAccountsReceivable
3
CY2023Q4 us-gaap Share Based Compensation
ShareBasedCompensation
1195000
CY2022Q4 us-gaap Share Based Compensation
ShareBasedCompensation
1771000
us-gaap Share Based Compensation
ShareBasedCompensation
2403000
us-gaap Share Based Compensation
ShareBasedCompensation
3836000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2023Q4 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2023Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
23815000
CY2022Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
25600000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
47991000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
50363000
CY2023Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
23815000
CY2022Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
25600000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
47991000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
50363000
CY2023Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
23815000
CY2022Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
25600000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
47991000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
50363000
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
40880000
CY2023Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
47762000
CY2023Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
2991000
CY2023Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
2101000
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
43871000
CY2023Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
49863000
CY2023Q4 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
10500000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
23400000
CY2023Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
77900000
CY2023Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
55800000
CY2023Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
22100000
CY2023Q4 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
2185000
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-104000
us-gaap Net Income Loss
NetIncomeLoss
4781000
us-gaap Net Income Loss
NetIncomeLoss
-120000
CY2023Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.07
CY2022Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.15
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2023Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.07
CY2022Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.15
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2023Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31179000
CY2022Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32018000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31329000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31975000
CY2023Q4 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
664000
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
662000
CY2023Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31843000
CY2022Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32018000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31991000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31975000
CY2023Q4 us-gaap Operating Lease Expense
OperatingLeaseExpense
325000
CY2022Q4 us-gaap Operating Lease Expense
OperatingLeaseExpense
315000
us-gaap Operating Lease Expense
OperatingLeaseExpense
650000
us-gaap Operating Lease Expense
OperatingLeaseExpense
636000
CY2023Q4 us-gaap Operating Lease Payments
OperatingLeasePayments
276000
us-gaap Operating Lease Payments
OperatingLeasePayments
590000
CY2022Q4 us-gaap Operating Lease Payments
OperatingLeasePayments
295000
us-gaap Operating Lease Payments
OperatingLeasePayments
593000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2200000
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2797000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
587000
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
832000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1470000
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1762000
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y2M23D
CY2023Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y4M24D
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0500
CY2023Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0497
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
342000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
668000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
688000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
527000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
2225000
CY2023Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
168000
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
2057000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
587000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1470000
egan Warranty Period Maximum
WarrantyPeriodMaximum
P1Y
CY2023Q4 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
11200000
CY2023Q4 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
390842
CY2023Q4 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
6.39
CY2023Q4 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
2500000
us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
473898
us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
6.36
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
3000000.0
CY2023Q4 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001558370-24-000894-index-headers.html Edgar Link pending
0001558370-24-000894-index.html Edgar Link pending
0001558370-24-000894.txt Edgar Link pending
0001558370-24-000894-xbrl.zip Edgar Link pending
egan-20231231.xsd Edgar Link pending
egan-20231231x10q.htm Edgar Link pending
egan-20231231xex10d1.htm Edgar Link pending
egan-20231231xex31d1.htm Edgar Link pending
egan-20231231xex31d2.htm Edgar Link pending
egan-20231231xex32d1.htm Edgar Link pending
egan-20231231xex32d2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
egan-20231231_cal.xml Edgar Link unprocessable
egan-20231231_def.xml Edgar Link unprocessable
egan-20231231_lab.xml Edgar Link unprocessable
egan-20231231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
egan-20231231x10q_htm.xml Edgar Link completed
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending